Orion Corporation, one of the oldest confectionery and snack manufacturers in South Korea, has recalled its custard cream pie products. The company issued the recall after the country’s Ministry of Food and Drug Safety ordered it to do so.
According to The Korea Times, the custard cream products were manufactured at Orion’s factories in Cheongju, North Chungcheong Province. The MFDS said this week that it ordered Orion Corporation to recall some products after the harmful bacteria called staphylococcus aureus (staph) were found in the snack.
Effects of Staph Infection
The Food and Drug Ministry said this type of bacteria can lead to food poisoning. On top of this, staph may also cause various illnesses ranging from minor to life-threatening effects. Some of the effects can be minor skin infections to severe ailments like meningitis, toxic shock syndrome, and pneumonia.
For these health risks, Orion has been ordered to recall and stop the sale of its Custard snack item. The MDFS said it detected the bacteria in the particular product after randomly checking five Custard products for quality control.
Details of Recalled Batch
The agency said it had examined samples of 12 individually packed Custard creams. This batch was produced on Dec. 12, 2023, and bears the expiration date of June 21, 2024. The result showed that five of the sampled products were contaminated with the staph bacteria.
It was reported that the affected Custards are part of the 4,000 packs that were made in the mentioned manufacturing plant. This batch has a total weight of around 1,318 kilograms.
In response to the recall order, the MDFS said that Orion informed the ministry that it would recall a portion first. The company said it will initially pull out a batch weighing 600 kilos.
“The North Chungcheong Cheongju government has taken measures to swiftly recall the products,” Korea Joongang Daily quoted the Food and Drug Safety Ministry as saying in a statement. “Consumers who purchased the product should not consume it and return it to the place of purchase.”
Photo by: Orion Website


Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 



